HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T L Yue Selected Research

idoxifene

11/2000Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
11/2000Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T L Yue Research Topics

Disease

4Ischemia
11/2000 - 03/2000
3Hypertension (High Blood Pressure)
01/2007 - 08/2000
2Stroke (Strokes)
01/2007 - 09/2001
2Vascular System Injuries
11/2000 - 01/2000
2Neointima
11/2000 - 04/2000
2Atherosclerosis
04/2000 - 01/2000
1Malignant Hypertension
01/2007
1Hypertrophy
12/2000
1Endometrial Neoplasms (Endometrial Cancer)
11/2000
1Infarction (Infarctions)
10/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2000
1Myocardial Infarction
10/2000
1Heart Failure
08/2000
1Reperfusion Injury
03/2000

Drug/Important Bio-Agent (IBA)

2SaltsIBA
01/2007 - 09/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2001 - 11/2000
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2000 - 03/2000
2idoxifeneIBA
11/2000 - 11/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2000 - 01/2000
2AntioxidantsIBA
10/2000 - 08/2000
2Carvedilol (Coreg)FDA LinkGeneric
10/2000 - 08/2000
2CytokinesIBA
04/2000 - 01/2000
1p38 Mitogen-Activated Protein KinasesIBA
01/2007
1Antihypertensive Agents (Antihypertensives)IBA
01/2007
1Plasminogen Activators (Plasminogen Activator)IBA
01/2007
1Biomarkers (Surrogate Marker)IBA
01/2007
1Plasminogen Activator Inhibitor 1IBA
01/2007
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2007
1OsteopontinIBA
01/2007
1Peroxynitrous Acid (Peroxynitrite)IBA
09/2001
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
12/2000
1Endothelin-1 (Endothelin 1)IBA
12/2000
1Selective Estrogen Receptor Modulators (SERM)IBA
11/2000
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2000
1Vasodilator Agents (Vasodilators)IBA
11/2000
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2000
1Estrogens (Estrogen)FDA Link
11/2000
1Adrenergic Receptors (Adrenergic Receptor)IBA
10/2000
1Bisoprolol (Concor)FDA LinkGeneric
10/2000
1GTP-Binding Proteins (G-Protein)IBA
10/2000
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
10/2000
1Peroxidase (Myeloperoxidase)IBA
10/2000
1Metoprolol (Toprol-XL)FDA LinkGeneric
08/2000
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2000
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2000
1Interleukin-1 (Interleukin 1)IBA
04/2000
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
03/2000
1Transforming Growth Factor beta (TGF-beta)IBA
01/2000
1Messenger RNA (mRNA)IBA
01/2000

Therapy/Procedure

1Therapeutics
11/2000